Urology
GMC: 4626222
Professor Greg Shaw is a highly-respected and globally-recognised consultant urological surgeon based in London who specialises in prostate cancer, in particular robotic surgery, prostatectomy alongside urinary tract infection and urinary problems. He practises at The Prostate Centre, near Harley Street, while his NHS base is University College London Hospitals NHS Foundation Trust.
Professor Shaw is highly qualified with a BSc, MBBS and MD from the University of London, as well as an MRCS and FRCS (Urol) from the Royal College of Surgeons of England. After developing an interest in prostate cancer whilst undertaking his MD, he began his specialist urologist training in North London where he was awarded his urology fellowship.
Following this, he completed a four year lectureship at The University of Cambridge where he worked in a world-class research team, generated important research findings and was awarded a fellowship in robotic surgery.
Professor Shaw has performed over 1,300 robotic radical prostatectomies to date and strives to evaluate and incorporate the best technical modifications to attain excellent results. He prides himself in his very low complication rate.
Furthermore, he has developed several research collaborations including an enhanced recovery program for radical prostatectomy at his NHS base, safely increasing the number of patients being discharged home the day after robotic prostate removal. He also has developed and presented a novel surgical technique called complete urethral preservation during robotic assisted radical prostatectomy (RARP) which gives many patients immediate urinary continence.
Professor Shaw, who is a spokesperson for The Orchid Cancer Appeal, is a Professor of Urology at University of College London where he is leading the NeuroSAFE PROOF study to evaluate the cost effectiveness of the NeuroSAFE procedure during radical prostatectomy and the C-PRO-META study to evaluate the prognostic utility of circulating tumour cells in men undergoing surgery for prostate cancer. He has been awarded prizes for lectures delivered at international and national conferences, and one research project he conducted led to significant media interest including a front page article in The Daily Telegraph alongside global press coverage.
Professor Shaw's reputation clinical research also extends to his work as lead for Urology for the National Institute for Health Research (NIHR) for North Thames, while he was also involved in staff training for the NHS Nightingale Hospital in London. Furthermore he is a research consultant for the Royal College of Surgeons of England and has been a Clinical Studies Group member for the National Cancer Research Institute (NCRI).
Professor Shaw has published over 100 PubMed-linked papers, authored several book chapters and various other peer-reviewed articles. Furthermore, he's Consultant Editor for uro-oncology for the British Journal of Urology International Knowledge project, where the team has developed an online curriculum supporting urology trainees and established consultants in their continued professional development.
Professor Shaw is a member of various professional organisations including the British Association of Urological Surgeons (BAUS), the European Association of Urology (EAU) and the Royal College of Surgeons of England.
In this article here, esteemed consultant urologist, Professor Greg Shaw, talks at length about PSA testing, breaking down what factors lead to a raised PSA, and how this type of test can help in either ruling out or diagnosing prostate cancer.
In his latest online article Professor Greg Shaw gives us his insights into NeuroSafe. He explains what it is, the benefits, the technique and how it has improved radical prostatectomy.
MRI fusion biopsy is currently the gold standard diagnostic method when it comes to accurately detecting prostate cancer and guiding the biopsy process. Top Doctors speaks to highly-respected and globally-recognised consultant urological surgeon Professor Greg Shaw all about it, including why it’s required, what’s involved and if it’s painful.
Here, Professor Greg Shaw, an esteemed consulgtant urologist, describes what a robotic radical prostatectomy is in expert detail.
This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.